
Science Resources RSS Feeds
|
 |
 |
 |
Are angiotensins involved in the hemodynamic changes of cirrhosis patients?
June 12, 2009
Liver cirrhosis has been recently studied in the light of the new view of the renin angiotensin system (RAS). While the angiotensin converting enzyme (ACE)-Ang 2-AT1 receptor arm contributes to liver tissue injury and fibrosis and the maintenance of basal vascular tonus in non-compensated cirrhosis, the activation of the ACE2-Ang-(1-7)-Mas receptor arm exerts anti-fibrotic actions and probably has also a role in arterial vasodilation in liver cirrhosis. In a previous study published last year in WJG by the same research group, it was shown that chronic treatment with propranolol in cirrhotic patients was characterized by marked changes in the precursors of the RAS cascade (renin and Ang 1 with repercussions on the 2 main RAS components, Ang 2 and Ang-(1-7), in the splanchnic and peripheral circulation. Therefore, the circulating profile of RAS components at different stages of liver cirrhosis and their role in hemodynamic changes of cirrhosis remained unclear. A research article to be published in May 28, 2009 in the World Journal of Gastroenterology addressed this issue. The research team led by Prof. Santos from the Federal University of Minas Gerais measured the circulating levels of angiotensins in patients at different stages of liver cirrhosis by radioimmunoassay, and further evaluated the influence of RAS components on hemodynamic changes during liver transplantation.
The study showed that the progression of liver dysfunction is characterized by marked changes in circulating Ang-(1-7) and Ang 2 levels. In the initial stages, there were a predominance of Ang-(1-7) rather than Ang 2. On the other hand, advanced stages of cirrhosis showed an activation of the peripheral and splanchnic RAS, and a deviation toward the formation of Ang-(1-7) in the splanchnic circulation. Furthermore, there was a positive correlation between the Ang-(1-7)/Ang 2 ratio and cardiac output and a negative correlation between this ratio and systemic vascular resistance, indicating that the final functional effects of the RAS may reflect a balance between these 2 opposing peptides.
The relationship between Ang-(1-7) and Ang 2 may play a role in hemodynamic changes of human cirrhosis. The peptide Ang-(1-7) probably predominates in the peripheral circulation in the initial stages of human cirrhosis and in the splanchnic circulation in the advanced stages, both contributing to a reduction in vascular resistance and consequently to hyperdynamic circulation. In the peripheral circulation of patients with advanced cirrhosis, when compared to the splanchnic circulation, Ang 2 probably leads to extra-splanchnic vasoconstriction. Although further studies with a larger number of patients should address the precise role of RAS in human cirrhosis, this research opens the possibility that future therapies interfering with the RAS in both the systemic and splanchnic circulation should lead to more success in the management of the hemodynamic changes in human cirrhosis.
World Journal of Gastroenterology
|
 |
Related Cirrhosis Current Events and Cirrhosis News Articles Cirrhosis Current Events and Cirrhosis News RSS Toward explaining why hepatitis B hits men harder than women Scientists in China are reporting discovery of unusual liver proteins, found only in males, that may help explain the long-standing mystery of why the hepatitis B virus (HBV) sexually discriminates -- hitting men harder than women.
Unexplained liver hemorrhage after metastasis radiofrequency ablation Colorectal carcinoma is one of the most common cancers in the world. Approximately one in four of these patients have metastases at diagnosis, liver being the most common site involved.
The use of stem cells in regenerative medicine may also be detrimental for health The use of stem cells in regenerative medicine is not always beneficial for human health, it may even be harmful according to a work done by the University of Granada and University of León. Scientists have demonstrated that transplantation of human mononuclear cells isolated from umbilical cord blood exerted a deleterious effect in rats with liver cirrhosis.
Alcohol Tolerance Switch Found in Fruit Flies Researchers at North Carolina State University have found a genetic "switch" in fruit flies that plays an important role in making flies more tolerant to alcohol.
UCSD researchers pave the way for effective liver treatments A combination of bioengineering and medical research at the University of California, San Diego has led to a new discovery that could pave the way for more effective treatments for liver disease.
Discovery could improve hepatitis C treatment Walter and Eliza Hall Institute researchers are part of an international team that has discovered a genetic variation that could identify those people infected with hepatitis C who are most likely to benefit from current treatments.
What are the risk factors for rebleeding after negative angiography? Acute non-variceal gastrointestinal bleeding accounts for approximately 20% of emergency room visits and 5% of admissions.
HBV genotype B/B3 and C/C1 are the major genotypes in Indonesia? Previous studies revealed that HBV genotypes as well as mutations in the core promoter, precore or HBx gene have been shown to have an association with the clinical outcome of liver disease, however, this is still controversial.
Is endotoxin receptor CD14 rs2569190/C-159T gene correlated with chronic hepatitis C? It is still unknown why the natural history of chronic disease caused by hepatitis C virus (HCV), which currently infects 3% of the world's population, varies from mild in some patients to rapidly progressing in others.
Hepatitis C virus channels efforts into cell survival Researchers at the University of Leeds have discovered a previously unknown mechanism that allows the hepatitis C virus (HCV) to remain in the body for decades. More Cirrhosis Current Events and Cirrhosis News Articles
|
 |

|
The First Year: Cirrhosis: An Essential Guide for the Newly Diagnosed (First Year, The)
by James L. Dickerson (Author), Fredric Regenstein (Foreword)
More than 25 million Americans and 92 million worldwide suffer from liver disease and cirrhosis, a degenerative and potentially fatal condition in which liver cells are damaged and then replaced by scar tissue, impeding liver function. The disease is most commonly caused by excessive alcohol consumption, hepatitis, or complications from prescription drugs. Immediately after his diagnosis, James Dickerson set out to educate himself on all of his options — and found there is hope for recovery. Now, he offers The First Year: Cirrhosis, the first guide for patients and their families to understanding and managing this chronic condition. In clear, accessible language, the book walks readers step-by-step through everything they need to do each day of the first week after a cirrhosis...
|

|
The Official Patient's Sourcebook on Cirrhosis of the Liver: A Revised and Updated Directory for the Internet Age
by ICON Health Publications (Author)
This book has been created for patients who have decided to make education and research an integral part of the treatment process. Although it also gives information useful to doctors, caregivers and other health professionals, it tells patients where and how to look for information covering virtually all topics related to cirrhosis of the liver (also liver cirrhosis), from the essentials to the most advanced areas of research. The title of this book includes the word official. This reflects the fact that the sourcebook draws from public, academic, government, and peer-reviewed research. Selected readings from various agencies are reproduced to give you some of the latest official information available to date on cirrhosis of the liver. Given patients' increasing sophistication in using...
|

|
The Liver Book: A Comprehensive Guide to Diagnosis, Treatment, and Recovery
by Sanjiv Chopra (Author)
It is the portal to total body wellness, the great purifier, and the only human organ that can regenerate itself. But what you don't know about the liver can hurt you! Now, in this complete and authoritative guide that anyone can use and understand, Dr. Sanjiv Chopra explains: The what, where, how, and why of the liver and its miraculous functions How doctors diagnose liver ailments Tests and screenings: what to expect and what they reveal Vital information on hepatitis B (the chronic condition that currently afflicts 300 million people) and all the important facts about hepatitis C (approximately 200 million people currently infected) Liver transplants The role of alternative treatments The risk factors, symptoms, treatment, and prevention of liver...
|

|
The Official Patient's Sourcebook on Primary Biliary Cirrhosis
by James N. Parker (Editor), Philip M. Parker (Editor)
This book has been created for patients who have decided to make education and research an integral part of the treatment process. Although it also gives information useful to doctors, caregivers and other health professionals, it tells patients where and how to look for information covering virtually all topics related to primary biliary cirrhosis (also Cholangiolitic biliary cirrhosis; Hanot syndrome; Hypertrophic cirrhosis of Hanot), from the essentials to the most advanced areas of research. The title of this book includes the word official. This reflects the fact that the sourcebook draws from public, academic, government, and peer-reviewed research. Selected readings from various agencies are reproduced to give you some of the latest official information available to date on primary...
|
![A Dog Called Cirrhosis [Explicit]](http://ecx.images-amazon.com/images/I/51JgXln1HRL._SL160_.jpg)
|
A Dog Called Cirrhosis [Explicit]
Brzowski & Moshe (Primary Contributor)
|

|
Dr. Melissa Palmer's Guide To Hepatitis and Liver Disease
by Melissa Palmer (Author)
In the United States alone, more than four million people are infected with the hepatitis C virus, and chronic liver disease is the twelfth leading cause of death.
In this revised and updated edition of her groundbreaking 2000 book, renowned hepatologist Dr. Melissa Palmer discusses all facets of liver disease, from symptoms and tests to treatment options and lifestyle changes. In addition, this comprehensive handbook reveals cutting-edge research on the dangers of hepatitis C, one of the world's fasting-growing microbial threats.
|
|
|
Alcoholic Death Noise
by Cirrhosis
|

|
Primary Biliary Cirrhosis Awareness Ribbon Mouse Pad
by MyHeritageWear.com
The Primary Biliary Cirrhosis Ribbon proudly displayed on a mouse pad. There is no better way to achieve awareness for the meaning of the Primary Biliary Cirrhosis Ribbon than to display it on your mouse pad for everyone to see. The mouse pad measures at 9.25 x 7.75, it is machine washable, and the colors will not fade or run. Start gaining awareness today by presenting your Primary Biliary Cirrhosis Ribbon mouse pad at work or at home. It is certain to keep your mouse rolling in style all while gaining support and awareness!
|

|
Milk Thistle 175mg - 60 - Capsule
by Bluebonnet
MILK THISTLE EXTRACT 175 mg. Vcaps Pure Indena® milk thistle seed extract imported from Europe. Including e - d - s, an enzyme delivery system from 100% plant sources. Available in easy-to-swallow vegetable capsules for maximum assimilation and absorption.
|

|
FlameEz-Liver, 60 Capsules/Bottle
by FlameEz
There are many types of liver disease. Whether the liver is infected with a virus or injured by chemicals, the process of the liver damage always involves inflammation. If properly treated, the inflammation may go away and the liver can heal itself. If left untreated, the inflamed liver will start to scar. As excess scar tissue grows, it replaces healthy liver tissue and leads to fibrosis or cirrhosis. Although it is important to treat the liver disease in the inflammation and fibrosis stages, the treatment choice is limited because many drugs are metabolized by the liver and a few drugs that are used routinely to treat liver disease have significant side effects. Natural remedies are available as alternative approach for liver disease. FlameEz-Liver is a high quality natural liver...
|
|